Quince Therapeutics Inc (QNCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,140 | -12,254 | -51,660 | -46,126 | -38,205 |
| Depreciation Amortization | 5,316 | 5,778 | 916 | 1,070 | 297 |
| Income taxes - deferred | -248 | -248 | -284 | -284 | -284 |
| Accounts payable and accrued liabilities | -216 | 1,081 | -5,943 | -5,329 | -4,664 |
| Other Working Capital | 1,806 | 1,605 | -9,829 | -8,062 | -7,781 |
| Other Operating Activity | 3,086 | 469 | 22,762 | 20,528 | 19,131 |
| Operating Cash Flow | $-7,396 | $-3,569 | $-44,038 | $-38,203 | $-31,506 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 82,493 | N/A | 34,388 |
| PPE Investments | -46 | -46 | -63 | 15 | 30 |
| Net Acquisitions | N/A | N/A | 10,593 | N/A | N/A |
| Purchase Of Investment | -50,131 | -7,691 | -75,021 | -66,767 | -36,849 |
| Sale Of Investment | 35,394 | 13,277 | N/A | 55,495 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 10,593 | 10,593 |
| Investing Cash Flow | $-14,783 | $5,540 | $18,002 | $-664 | $8,162 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | -6 | -49 | -31 | -12 |
| Common Stock Issued | 82 | 56 | 756 | 756 | 742 |
| Financing Cash Flow | $76 | $50 | $707 | $725 | $730 |
| Exchange Rate Effect | 174 | 114 | 184 | 227 | -182 |
| Beginning Cash Position | 44,579 | 44,579 | 69,724 | 69,724 | 69,724 |
| End Cash Position | 22,650 | 46,714 | 44,579 | 31,809 | 46,928 |
| Net Cash Flow | $-21,929 | $2,135 | $-25,145 | $-37,915 | $-22,796 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,396 | -3,569 | -44,038 | -38,203 | -31,506 |
| Capital Expenditure | -136 | -136 | -133 | -55 | -5 |
| Free Cash Flow | -7,532 | -3,705 | -44,171 | -38,258 | -31,511 |